Developing effective strategies for preventing breast cancer-related arm lymphedema (BCRAL) remains a significant unmet need in healthcare, as there are currently no effective treatments...
Greenwich LifeSciences has shared important updates on the phase 3 Flamingo-01 trial, which is researching GLSI-100, a new immunotherapy for patients with a specific...
Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...
A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...